Amalendu P Ranjan
Overview
Explore the profile of Amalendu P Ranjan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
245
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ranjan A, Czyzyk D, Martinez-Traverso G, Sadiqova A, Valhondo M, Schaefer D, et al.
RSC Pharm
. 2024 Oct;
1(5):963-975.
PMID: 39372445
The gastrointestinal disease cryptosporidiosis, caused by the genus , is a common cause of diarrheal diseases in children, particularly in developing countries and frequently fatal in immunocompromised individuals. ()-specific bifunctional...
2.
Papini C, Ullah I, Ranjan A, Zhang S, Wu Q, Spasov K, et al.
Proc Natl Acad Sci U S A
. 2024 Apr;
121(17):e2320713121.
PMID: 38621119
As the SARS-CoV-2 virus continues to spread and mutate, it remains important to focus not only on preventing spread through vaccination but also on treating infection with direct-acting antivirals (DAA)....
3.
Lampe J, Desai P, Tripathi A, Sabnis N, Chen Z, Ranjan A, et al.
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839985
Bone-metastatic prostate cancer symbolizes the beginning of the later stages of the disease. We designed a cabazitaxel-loaded, poly (lactic-co-glycolic acid) (PLGA) nanoparticle using an emulsion-diffusion-evaporation technique. Bis (sulfosuccinimidyl) suberate (BS3)...
4.
Gdowski A, Hayatshahi H, Fudala R, Joshi R, Liu J, Vishwanatha J, et al.
Pharmaceutics
. 2022 Jan;
14(1).
PMID: 35057024
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive malignancies and is the fourth leading cause of cancer-related deaths in the United States. Unfortunately, 80-85% of patients are diagnosed...
5.
Gdowski A, Lampe J, Lin V, Joshi R, Wang Y, Mukerjee A, et al.
ACS Appl Nano Mater
. 2021 Feb;
2(10):6249-6257.
PMID: 33585803
Targeting therapeutic agents to specific organs in the body remains a challenge despite advances in the science of systemic drug delivery. We have engineered a programmable-bioinspired nanoparticle (P-BiNP) delivery system...
6.
Kumar P, Treuren T, Ranjan A, Chaudhary P, Vishwanatha J
Nanotechnology
. 2019 Mar;
30(26):265101.
PMID: 30865940
Brain metastatic breast cancer is challenging to treat due to the presence of the blood-brain barrier (BBB) and a lack of ability to target precisely. Most drugs fail to cross...
7.
Pieretti S, Ranjan A, Di Giannuario A, Mukerjee A, Marzoli F, Di Giovannandrea R, et al.
Colloids Surf B Biointerfaces
. 2017 Jul;
158:379-386.
PMID: 28719859
Given the poor bioavailability of curcumin, its antinociceptive effects are produced after chronic intravenous administration of high doses, while poly (d,l-lactide-co-glycolide)-loaded vesicles (PLGA) can improve drug delivery. This paper investigates...
8.
Ranjan A, Mukerjee A, Gdowski A, Helson L, Bouchard A, Majeed M, et al.
J Biomed Nanotechnol
. 2016 Jun;
12(4):679-88.
PMID: 27301194
Non-small-cell lung cancer therapy is a challenge due to poor prognosis and low survival rate. There is an acute need for advanced therapies having higher drug efficacy, low immunogenicity and...
9.
Nanoparticle Effects on Human Platelets in Vitro: A Comparison between PAMAM and Triazine Dendrimers
Enciso A, Neun B, Rodriguez J, Ranjan A, Dobrovolskaia M, Simanek E
Molecules
. 2016 Apr;
21(4):428.
PMID: 27043508
Triazine and PAMAM dendrimers of similar size and number of cationic surface groups were compared for their ability to promote platelet aggregation. Triazine dendrimers (G3, G5 and G7) varied in...
10.
Gdowski A, Ranjan A, Mukerjee A, Vishwanatha J
Adv Exp Med Biol
. 2014 Mar;
807:33-58.
PMID: 24619617
The ability to detect many cancers at an early stage in its clinical course has the potential to improve patient outcomes in terms of morbidity and mortality. Nanosized components incorporated...